Skip to NavigationSkip to content

all trials

Diabetes drug risks fuel transparency debate

Channel 4 image

A new investigation by Channel 4’s Dispatches and the British Medical Journal is demanding that all trial data be released on new diabetes medicines as safety fears rise. 

The investigation, which aired on the UK’s Channel 4 this week, looked at a new branch of treatment for type II diabetes known as GLP-1 drugs, which include Novo Nordisk’s Victoza and AstraZeneca/Bristol-Myers Squibb’s Byetta.

‘No consensus’ on transparency

ABPI image

An ABPI meeting on increasing the transparency of the way clinical trials are reported has thrown up more questions than answers, not least in terms of what ‘transparency’ should actually mean.

The half-day workshop was attended by stakeholders including the Department of Health and Wellcome Trust, plus pharma companies including AstraZeneca and Shire, along with Dr Sarah Wollaston, Conservative MP and member of the health select committee.

Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches